XNPT Share Price

Open 7.03 Change Price %
High 7.07 1 Day 0.05 0.71
Low 7.02 1 Week 0.00 0.00
Close 7.07 1 Month 0.00 0.00
Volume 2615875 1 Year 1.15 19.43
52 Week High 7.10
52 Week Low 3.70
XNPT Important Levels
Resistance 2 7.12
Resistance 1 7.10
Pivot 7.05
Support 1 7.04
Support 2 7.02
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SIRI 4.33 0.70%
SUSQ 14.20 -0.77%
AAPL 109.10 -0.73%
AAPL 109.10 -0.73%
More..
NASDAQ USA Top Gainers Stocks
QKLS 0.21 110.00%
LLEN 0.03 50.00%
LOCM 0.09 50.00%
RITT 0.09 50.00%
MEMP 0.64 33.33%
SKBI 0.19 26.67%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CLNT 0.88 23.94%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LIWA 0.01 -50.00%
AMCF 0.03 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

XenoPort, Inc. (NASDAQ: XNPT)

XNPT Technical Analysis 5
As on 5th Jul 2016 XNPT Share Price closed @ 7.07 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.44 & Strong Buy for SHORT-TERM with Stoploss of 5.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
XNPT Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
XNPT Other Details
Segment EQ
Market Capital 330802368.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.xenoport.com
XNPT Address
XNPT
3410 Central Expressway
Santa Clara, CA 95051
United States
Phone: 408-616-7200
XNPT Latest News
XenoPort, Inc. (NASDAQ:XNPT) Strong Buy Ratings At 0   Markets Daily   - 05th Dec 16
XenoPort, Inc. (NASDAQ:XNPT) Posted Basic Consolidated EPS Of $-1.3026   Equities Focus   - 05th Dec 16
Rating Sentiment Alert: Analysts take a look at XenoPort, Inc. (NASDAQ:XNPT ...   MoneyMakingArticles   - 11th Nov 16
Arbor Pharmaceuticals Completes Successful Tender Offer for Shares of XenoPort   Business Wire (press release)   - 05th Jul 16
Arbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act ...   Business Wire (press release)   - 16th Jun 16
Why Xenoport, Inc. Stock Jumped 61.1% in May   Motley Fool   - 04th Jun 16
Why XenoPort, Inc. Is Skyrocketing 56.6% Today   Motley Fool   - 23rd May 16
Biopharmaceutical company Xenoport explores sale: sources   Reuters   - 22nd Jan 16
Why XenoPort, Inc. Shares Tanked Today   Motley Fool   - 04th Feb 15
/quotes/zigman/3870025/realtime   MarketWatch   - 30th Jun 09
Interactive Technical Analysis Chart XenoPort, Inc. ( XNPT NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on XenoPort, Inc.
XNPT Business Profile
XenoPort, Inc. is a biopharmaceutical company focused on developing and commercializing a portfolio of internally for the treatment of neurological disorders. The product candidates are prodrugs that are created by modifying the chemical structure of marketed drugs, referred to as parent drugs, and are designed to correct limitations in the oral absorption, distribution and/or metabolism of the parent drug. The Company focuses its development and commercialization efforts on treatments of diseases with unmet medical needs, with an emphasis on central nervous system disorders. The products are designed to correct limitations in the oral absorption, distribution and/or metabolism of the parent drug. In April 2011, the United States Food and Drug Administration (FDA), approved the Company�s first product, known in the United States as Horizant (gabapentin enacarbil) Extended-Release Tablets, for the treatment of moderate-to-severe primary restless legs syndrome, or RLS, in adults.